In terms of mood, isoliquiritigenin hits a very unique range of targets. As we mentioned earlier, the bulk of its effects are coming from the GABAergic system. Isoliquiritigenin acts as a positive allosteric modulator of GABA-A receptors, which means that the GABA-A receptors are becoming more sensitive to the effects of endogenous GABA and other GABAergics. This mechanism of action usually produces a very relaxed mood. The second effect isoliquiritigenin has, is that it activates another GABA receptor, the GABA-B receptor. GABA-B receptor activation usually leads to muscle relaxation in addition to a somewhat uplifted, yet relaxed mood state. Combining a GABA-A positive allosteric modulator with a GABA-B agonist, results in a very unique and pleasant relaxation effect. In isolation, this effects profile likely would cause some degree of lethargy for many people. However, isoliquiritigenin has some other tricks up its sleeve which prevents this from happening!
In addition to modulating the GABAergic system, isoliquiritigenin also modulates the monoamine system. It does this by inhibiting both of the monoamine oxidase enzymes, MAO-A and MAO-B. These enzymes normally degrade monoamine neurotransmitters such as dopamine, norepinephrine and serotonin. Thus, by inhibiting MAO-A and MAO-B, isoliquiritigenin can slow down the degradation of monoamine neurotransmitters, thereby producing elevated levels of dopamine, norepinephrine and serotonin. This produces a crisp stimulating effect which contrasts very nicely with the GABAergic effects of isoliquiritigenin. Due to this, isoliquiritigenin can be very calming and mood boosting, while also not producing much if any lethargy. This makes isoliquiritigenin an excellent choice for taking the edge off during the day! The mix of GABAergic and monoaminergic effects reminds us a lot of the classic caffeine + L-theanine stack, which also contrasts a calming effect with a stimulating effect. However, in the case of isoliquiritigenin we find the effects to be even smoother and much more mood boosting!
Isoliquiritigenin also has some very unique direct effects on the dopaminergic system. It acts as an agonist at dopamine D3, while acting as an antagonist at dopamine D1. The dopamine D3 receptor has a major effect on mood, and dopamine D3 agonists have been shown to be potent mood enhancers. While it is not entirely clear what kind of effect dopamine D1 antagonism would have in the context of the effects profile of isoliquiritigenin, research on dopamine D1 antagonists seems to indicate that they may have a calming effect, while also smoothing locomotor function. Additionally, isoliquiritigenin also appears to be an agonist of the Vasopressin receptor 1A. This is a very unique target, and may have beneficial effects on socializing! Overall, when combining all of the unique neurological targets of isoliquiritigenin, it is likely easy to see why it has such a unique mood boosting effect!
Isoliquiritigenin also has a unique pain management effect. This is partially coming from the muscle relaxation effects that are being mediated by GABA-B agonism, but this is further getting ramped up by isoliquiritigenin’s prominent inflammation balancing effects. Pair this with the sodium channel inhibitor effects of isoliquiritigenin, and you end up with a very comprehensive pain modulating effect.
Moving down into the gut, isoliquiritigenin also exerts some highly beneficial effects. First and foremost, it produces a robust gastroprotective effect. This effect is likely being mediated by isoliquiritigenin’s ability to support COX-2 levels in the stomach. Furthermore, isoliquiritigenin also has a positive effect on our gut microflora. It enhances the growth and diversity of gut bacteria, likely by acting as a prebiotic.
As if the list of benefits couldn’t get any longer, isoliquiritigenin also appears to have beneficial effects on both cardiovascular and metabolic health. The bulk of the metabolic effects are likely being mediated by isoliquiritigenin’s AMPA activation effects and mTORC1 inhibition. The majority of the cardiovascular benefits seem to be mediated via isoliquiritigenin’s oxidation balancing effect and its platelet activity modulating effect. The oxidation modulating effects are mainly mediated through Nrf2 and HO-1 activation.